Clinical Trial Update: A Study of IBI3032 in Chinese Healthy Participants and Participants With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating IBI3032 in healthy Chinese participants and individuals with overweight or obesity; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• IBI3032

Snippet

Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) | Conditions: Part A: Healthy Part B: Overweight or Obesity | Phase 1 | Status: RECRUITING